Pfizer and BioNTech’s COVID-19 vaccine for adolescents aged between 12 and 15 years has been granted full approval by the U.S. Food and Drug Administration (FDA), the companies announced on Friday.
The vaccine will be sold under the brand name Comirnaty and is the first and only COVID-19 vaccine to be granted FDA approval for children aged 12 and older, having been available under an emergency use authorization since May 2021 for the 12–15 age group.
